Blood MAPT expression and methylation status in Alzheimer's disease

Blood MAPT expression and methylation status in Alzheimer's disease

Abstract Aim This study aimed to investigate the expression levels and methylation status of microtubule‐associated protein tau (MAPT) in the blood of Alzheimer's disease (AD) patients and age‐ and sex‐matched healthy controls. Methods Fifty AD outpatients and 50 healthy contorls were enrolled....

Full description

Bibliographic Details
Main Authors:	Hiroaki Mori, Yuta Yoshino, Mariko Ueno, Yu Funahashi, Hiroshi Kumon, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Jun‐ichi Iga, Shu‐ichi Ueno
Format:	Article
Language:	English
Published:	Wiley 2022-12-01
Series:	PCN Reports
Subjects:	Alzheimer's disease blood gene expression gene methylation MAPT
Online Access:	https://doi.org/10.1002/pcn5.65

Similar Items

MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer
by: Wang C, et al.
Published: (2019-08-01)

DNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia Subjects
by: Yuta Yoshino, et al.
Published: (2017-05-01)

Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers
by: Yiyuan Pan, et al.
Published: (2018-02-01)

Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology
by: Tara M. Caffrey, et al.
Published: (2007-07-01)

Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration
by: Lucia AA Giannini, et al.
Published: (2023-08-01)

Effects of gestational haloperidol exposure on mRNA expressions related to glutamate and GABA receptors in offspring
by: Hiroshi Kumon, et al.
Published: (2023-12-01)

Evolutionary perspective of Big tau structure: 4a exon variants of MAPT
by: Itzhak Fischer
Published: (2022-12-01)

Navigating the ALS Genetic Labyrinth: The Role of MAPT Haplotypes
by: Ivan Tourtourikov, et al.
Published: (2023-10-01)

MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features
by: Rebecca R. Valentino, et al.
Published: (2020-12-01)

Tau (MAPT) haplotypes in Jordan: new evidence on the Middle East as a melting-pot predating Neolithic migration
by: Almuthanna K. Alkaraki, et al.
Published: (2021-07-01)

Tau Isoforms: Gaining Insight into <i>MAPT</i> Alternative Splicing
by: Andrea Corsi, et al.
Published: (2022-12-01)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
by: Pascual Sánchez-Juan, et al.
Published: (2019-12-01)

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
by: Christina V. Tauber, et al.
Published: (2023-03-01)

An autopsied FTDP-17 case with MAPT IVS 10 + 14C > T mutation presenting with frontotemporal dementia
by: Ryohei Watanabe, et al.
Published: (2021-09-01)

A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy
by: Hang Li, et al.
Published: (2024-04-01)

Clinical features and biomarkers of semantic variant primary progressive aphasia with MAPT mutation
by: Jing Xu, et al.
Published: (2023-01-01)

The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review
by: He S, et al.
Published: (2018-06-01)

Dissecting the Clinical Heterogeneity and Genotype-Phenotype Correlations of MAPT Mutations: A Systematic Review
by: Cristina Villa, et al.
Published: (2024-01-01)

What’s in a Gene? The Outstanding Diversity of <i>MAPT</i>
by: Daniel Ruiz-Gabarre, et al.
Published: (2022-03-01)

MAPT Mutations V337M and N297K Alter Organelle Trafficking in Frontotemporal Dementia Patient-Specific Motor Neurons
by: Christiane Hartmann, et al.
Published: (2024-03-01)

Evaluation of a Frozen Micro-Agar Plates of MAPt Antibiotic Susceptibility Test for Enhanced Bioterror Preparedness
by: Shahar Rotem, et al.
Published: (2022-04-01)

MAPt: A Rapid Antibiotic Susceptibility Testing for Bacteria in Environmental Samples as a Means for Bioterror Preparedness
by: Ronit Aloni-Grinstein, et al.
Published: (2020-11-01)

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies
by: Amy Easton, et al.
Published: (2022-09-01)

Distinct cell type-specific protein signatures in GRN and MAPT genetic subtypes of frontotemporal dementia
by: Suzanne S. M. Miedema, et al.
Published: (2022-07-01)

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia
by: Kunie Ando, et al.
Published: (2020-06-01)

Development of Novel Chemically-Modified Nucleic Acid Molecules for Efficient Inhibition of Human <i>MAPT</i> Gene Expression
by: Madhuri Chakravarthy, et al.
Published: (2020-06-01)

MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD
by: Lisanne Korn, et al.
Published: (2023-02-01)

Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation
by: Takeshi Ikeuchi, et al.
Published: (2011-09-01)

Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia
by: Paola Piscopo, et al.
Published: (2023-05-01)

Neural precursor cells are decreased in the hippocampus of the delayed carbon monoxide encephalopathy rat model
by: Shinichiro Ochi, et al.
Published: (2021-03-01)

Conserved gene signatures shared among MAPT mutations reveal defects in calcium signaling
by: Miguel A. Minaya, et al.
Published: (2023-02-01)

Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders
by: Mang Ching Lai, et al.
Published: (2017-10-01)

TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia.
by: Yoko Mori, et al.
Published: (2015-01-01)

Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants
by: Li-Chun Lin, et al.
Published: (2019-10-01)

Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R
by: Alexander Sandberg, et al.
Published: (2020-12-01)

Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
by: Frederic Sampedro, et al.
Published: (2018-05-01)

Multiple high dose tDCS sessions produces perceived improvement and stabilisation in a person with a MAPT gene, presenting clinically as semantic variant primary progressive aphasia with severe cognitive impairment
by: C. Roncero, et al.
Published: (2021-03-01)

DNA methylation in Parkinson disease
by: Elena V. Yakovenko, et al.
Published: (2020-12-01)

iPS Cell-Based Model for MAPT Haplotype as a Risk Factor for Human Tauopathies Identifies No Major Differences in TAU Expression
by: Tabea Strauß, et al.
Published: (2021-08-01)

The Potential Role of Serum Tau Protein (MAPT), Neuronal Cell Adhesion Molecule (NrCAM) and Neprilysin (NEP) in Neurodegenerative Disorders Development in Psoriasis—Preliminary Results
by: Anna Baran, et al.
Published: (2022-08-01)